Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Innospec Inc. (IOSP : NSDQ)

• Company Description    Innospec Inc. is an international specialty chemicals company. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. The Fuel Specialties business specializes in manufacturing and supplying fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions. Oilfield Services provides specialty chemicals to all elements of the oil & gas exploration and production industry. The Performance Chemicals business creates innovative technology-based solutions for the customers in the Personal Care, Home Care, Agrochemical, Mining and Industrial markets. Octane Additives produces octane improvers to enhance gasoline. Number of Employees: 2,450

• Price / Volume Information    Yesterday's Closing Price: $76.46 Daily Weekly Monthly 20 Day Moving Average: 173,641 shares Shares Outstanding: 24.78 (millions) Market Capitalization: $1,894.49 (millions) Beta: 1.06 52 Week High: $124.80 52 Week Low: $71.06 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 3.44% 0.73% 12 Week -7.81% -11.64% Year To Date -30.53% -39.28%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8310 SOUTH VALLEY HIGHWAY SUITE 350 - ENGLEWOOD,CO 80112 USA ph: 303-792-5554 fax: 303-792-5668 web.ir@innospecinc.com http://www.innospec.com

• General Corporate Information    Officers Patrick S. Williams - Chief Executive Officer and President Milton C. Blackmore - Chairman and Director Ian P. Cleminson - Executive Vice President and Chief Financial Offic Keller Arnold - Director David F. Landless - Director Peer Information Innospec Inc. (ENFY) Innospec Inc. (EMLIF) Innospec Inc. (GPLB) Innospec Inc. (BCPUQ) Innospec Inc. (CYT.) Innospec Inc. (SOA) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: CHEM-DIVERSIFD Sector: Basic Materials CUSIP: 45768S105 SIC: 2800 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/17/26 Share - Related Items Shares Outstanding: 24.78 Most Recent Split Date: 7.00 (2.00:1) Beta: 1.06 Market Capitalization: $1,894.49 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 2.20% Current Fiscal Quarter EPS Consensus Estimate: $1.24 Indicated Annual Dividend: $1.68 Current Fiscal Year EPS Consensus Estimate: $5.05 Payout Ratio: 0.32 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.07 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/17/26

• Fundamental Ratios P/E Current FY Estimate: 15.14 Trailing 12 Months: 14.68 PEG Ratio: - Price Ratios Price/Book: 1.46 Price/Cash Flow: 9.94 Price / Sales: 1.06 EPS Growth vs. Year Ago Period: -17.04% vs. Previous Quarter: -11.11% Sales Growth vs. Year Ago Period: -0.34% vs. Previous Quarter: 0.50% ROE 09/30/25 - 10.28 06/30/25 - 10.89 03/31/25 - 11.38 ROA 09/30/25 - 7.35 06/30/25 - 7.70 03/31/25 - 8.00 Current Ratio 09/30/25 - 2.78 06/30/25 - 2.87 03/31/25 - 2.73 Quick Ratio 09/30/25 - 1.81 06/30/25 - 1.88 03/31/25 - 1.85 Operating Margin 09/30/25 - 7.30 06/30/25 - 7.65 03/31/25 - 7.84 Net Margin 09/30/25 - -0.07 06/30/25 - 1.08 03/31/25 - 1.51 Pre-Tax Margin 09/30/25 - -0.83 06/30/25 - 1.03 03/31/25 - 1.70 Book Value 09/30/25 - 52.47 06/30/25 - 52.14 03/31/25 - 50.39 Inventory Turnover 09/30/25 - 3.97 06/30/25 - 4.03 03/31/25 - 4.08 Debt-to-Equity 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©